Literature DB >> 19792043

Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum.

Mary Kay Washington1, Jordan Berlin, Philip Branton, Lawrence J Burgart, David K Carter, Patrick L Fitzgibbons, Kevin Halling, Wendy Frankel, John Jessup, Sanjay Kakar, Bruce Minsky, Raouf Nakhleh, Carolyn C Compton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19792043      PMCID： PMC2901838          DOI： 10.5858/133.10.1539

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  37 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas?

Authors:  Gábor Cserni; Vincent Vinh-Hung; Tomasz Burzykowski
Journal:  J Surg Oncol       Date:  2002-10       Impact factor: 3.454

3.  Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities.

Authors:  Neal S Goldstein
Journal:  Am J Surg Pathol       Date:  2002-02       Impact factor: 6.394

4.  Histopathological identification of colon cancer with microsatellite instability.

Authors:  J Alexander; T Watanabe; T T Wu; A Rashid; S Li; S R Hamilton
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 5.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

6.  Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery.

Authors:  Kevin F Birbeck; Christopher P Macklin; Nicholas J Tiffin; Wendy Parsons; Michael F Dixon; Nicholas P Mapstone; Cedric R Abbott; Nigel Scott; Paul J Finan; David Johnston; Philip Quirke
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

7.  Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability.

Authors:  Joel K Greenson; Joseph D Bonner; Ofer Ben-Yzhak; Hector I Cohen; Ines Miselevich; Murray B Resnick; Philippe Trougouboff; Lynn D Tomsho; Evelyn Kim; Marcelo Low; Ronit Almog; Gad Rennert; Stephen B Gruber
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

8.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Authors:  Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

9.  Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy.

Authors:  Leyo Ruo; Satish Tickoo; David S Klimstra; Bruce D Minsky; Leonard Saltz; Madhu Mazumdar; Philip B Paty; W Douglas Wong; Steven M Larson; Alfred M Cohen; Jose G Guillem
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

10.  Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.

Authors:  Rafael G Amado; Michael Wolf; Marc Peeters; Eric Van Cutsem; Salvatore Siena; Daniel J Freeman; Todd Juan; Robert Sikorski; Sid Suggs; Robert Radinsky; Scott D Patterson; David D Chang
Journal:  J Clin Oncol       Date:  2008-03-03       Impact factor: 44.544
View more
  118 in total

1.  Can a gastrointestinal pathologist identify microsatellite instability in colorectal cancer with reproducibility and a high degree of specificity?

Authors:  Eli Brazowski; Paul Rozen; Sara Pel; Ziona Samuel; Irit Solar; Guy Rosner
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

2.  Colorectal Cancer OncoGuia: surgical pathology report guidelines.

Authors:  Xavier Sanjuán; Antonio Salas; Josep Lloreta; Paula Manchon Walsh
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

3.  A common variant in MTHFR influences response to chemoradiotherapy and recurrence of rectal cancer.

Authors:  Jason B Nikas; Janet T Lee; Elizabeth D Maring; Jill Washechek-Aletto; Donna Felmlee-Devine; Ruth A Johnson; Thomas C Smyrk; Patrick S Tawadros; Lisa A Boardman; Clifford J Steer
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

4.  Role of the Interval from Completion of Neoadjuvant Therapy to Surgery in Postoperative Morbidity in Patients with Locally Advanced Rectal Cancer.

Authors:  Campbell S D Roxburgh; Paul Strombom; Patricio Lynn; Mithat Gonen; Philip B Paty; Jose G Guillem; Garrett M Nash; J Joshua Smith; Iris Wei; Emmanouil Pappou; Julio Garcia-Aguilar; Martin R Weiser
Journal:  Ann Surg Oncol       Date:  2019-04-08       Impact factor: 5.344

5.  Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patients.

Authors:  Alban Zarzavadjian Le Bian; Christine Denet; Nicolas Tabchouri; Gianfranco Donatelli; Philippe Wind; Christophe Louvet; Mostefa Bennamoun; Christos Christidis; Thierry Perniceni; David Fuks; Brice Gayet
Journal:  Langenbecks Arch Surg       Date:  2018-04-27       Impact factor: 3.445

6.  Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.

Authors:  Tsuyoshi Konishi; Yoshifumi Shimada; Lik Hang Lee; Marcela S Cavalcanti; Meier Hsu; Jesse Joshua Smith; Garrett M Nash; Larissa K Temple; José G Guillem; Philip B Paty; Julio Garcia-Aguilar; Efsevia Vakiani; Mithat Gonen; Jinru Shia; Martin R Weiser
Journal:  Am J Surg Pathol       Date:  2018-06       Impact factor: 6.394

Review 7.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

8.  Effect of skip lymphovascular invasion on hepatic metastasis in colorectal carcinomas.

Authors:  Yosuke Okamoto; Hiroyuki Mitomi; Kazuhito Ichikawa; Shigeki Tomita; Takahiro Fujimori; Yoshinori Igarashi
Journal:  Int J Clin Oncol       Date:  2014-12-09       Impact factor: 3.402

9.  Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response?

Authors:  Clotilde Debove; Nathalie Guedj; Ecoline Tribillon; Léon Maggiori; Magaly Zappa; Yves Panis
Journal:  Int J Colorectal Dis       Date:  2016-03-07       Impact factor: 2.571

10.  Prognostic implications of the number of retrieved lymph nodes of patients with rectal cancer treated with preoperative chemoradiotherapy.

Authors:  In Ja Park; Chang Sik Yu; Seok-Byung Lim; Yong Sik Yoon; Chan Wook Kim; Tae Won Kim; Jong Hoon Kim; Jin Cheon Kim
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.